GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stemtech Corp (OTCPK:STEK) » Definitions » Issuance of Debt

STEK (Stemtech) Issuance of Debt : $1.29 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Stemtech Issuance of Debt?

Stemtech's Issuance of Debt for the three months ended in Sep. 2024 was $0.57 Mil.

Stemtech's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was $1.29 Mil.


Stemtech Issuance of Debt Historical Data

The historical data trend for Stemtech's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stemtech Issuance of Debt Chart

Stemtech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Issuance of Debt
0.56 3.32 1.22 2.24

Stemtech Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.46 - 0.26 0.57

Stemtech Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stemtech Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Stemtech's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Stemtech Business Description

Traded in Other Exchanges
N/A
Address
4851 Tamiami Trail North, Suite 200, Naples, FL, USA, 34103
Stemtech Corp is a nutraceutical company. Its products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where perform their daily function of renewal for optimal health. It markets its products under the following brands: RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze. Geographically, it derives a majority of its revenue from the Americas.
Executives
Charles Stuart Arnold director 520 BRICKELL KEY DR #1607, MIAMI FL 33131
Mindshare Holdings, Inc. 10 percent owner 419 BOSTWICK LANE, GAITHERSBURG MD 20878
Darryl V Green director 300 SIXTH AVENUE, PITTSBURGH PA 15222
John William Meyer director 10370 USA TODAY WAY, MIRAMAR FL 33025
Benjamin Nathaniel Kaplan director 13005 CORONOADO LANE, NORTH MIAMI FL 33181